Kayne Anderson Rudnick Investment Management
AGN

Kayne Anderson Rudnick Investment Management’s Allergan plc AGN Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-11
Closed -$2K – 661
2020
Q1 		$2K Hold
11
– – ﹤0.01% 555
2019
Q4 		$2K Buy
+11
New +$1.98K ﹤0.01% 600

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management's AGN Position: Q2 2020 in Review

Kayne Anderson Rudnick Investment Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 11 shares — an estimated $2K sold.

Kayne Anderson Rudnick Investment Management first reported a position in AGN in Q4 2019 and held it in 2 quarters. The position peaked at $2K in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Kayne Anderson Rudnick Investment Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Kayne Anderson Rudnick Investment Management sold 11 Allergan plc shares in Q2 2020, an estimated $2K.
  • Kayne Anderson Rudnick Investment Management first reported a position in Allergan plc in Q4 2019 and held it in 2 quarters.
  • Kayne Anderson Rudnick Investment Management's Allergan plc position peaked at $2K in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.